Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person5
BOSTON SCIENTIFIC CORP
Company
KEWAUNEE SCIENTIFIC CORP /DE/
Company
Core Scientific, Inc./tx
Company
BOSTON OMAHA Corp
Company
SCIENTIFIC INDUSTRIES INC
Company
Primary record16
BOSTON SCIENTIFIC CORP filed SCHEDULE 13G/A
0001104659-26-123910.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000885725 XXXXXXXX LIVE 1 Common Stock 09/30/2026 0001574094 RenovoRx, Inc. 75989R107 2570 West El Camino Real Suite 640 Mountain
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-11-06.
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-11-03.
BOSTON SCIENTIFIC CORP filed 8-K
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 28, 2026, Boston Scientific Corporation issued a press release announcing financial results for the third quarter ended September 30, 2026. A copy of t
PDS Biotechnology Corp filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Directors On October 18, 2026, each of Kamil Ali-J
BOSTON SCIENTIFIC CORP filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Operating Officer On October 7, 2026, Boston Scientific C
BOSTON SCIENTIFIC CORP filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 21, 2026, Arthur C. Butcher informed Boston Scient
PDS Biotechnology Corp filed 8-K
Item 1.02 Termination of a Material Definitive Agreement. On September 14, 2026, PDS Biotechnology Corporation (the “ Company ”) redeemed in full that certain Promissory Note, dated as of June 15, 2026, as amended by tha
BOSTON SCIENTIFIC CORP filed 8-K
Item 1.05 Material Cybersecurity Incidents. As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-09-03.
BOSTON SCIENTIFIC CORP filed 8-K
Item 8.01 Other Events. On August 25, 2026, Boston Scientific Corporation (the Company ) identified a cybersecurity incident affecting certain of its information technology systems that has resulted in a global disruptio
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-08-26.
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-08-12.
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-08-11.
BOSTON SCIENTIFIC CORP filed 4
SEC form 4 filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-08-07.
BOSTON SCIENTIFIC CORP filed 10-Q
SEC form 10-Q filed by BOSTON SCIENTIFIC CORP (CIK 885725) on 2026-08-03.